Program Schedule

1319
Using Anti-Inflammatories in HIV-Infected Patients

Session: Symposium: Interventions to Treat End Organ Disease in HIV Care
Saturday, October 11, 2014: 10:30 AM
Room: The Pennsylvania Convention Center: 120-ABC
Priscilla Hsue, MD, Medicine, University of California, San Francisco, San Francisco, CA

Dr. Priscilla Hsue is a Professor of Medicine at UCSF. Her research interest is in the pathogenesis, clinical manifestations, and treatment of cardiovascular disease and inflammation in HIV-infected patients. As Co-Director of the Center for Vascular Excellence at UCSF, she has extensive experience in ultrasound imaging including assessment of carotid artery intima-media thickness and assessment of endothelial function using flow-mediated vasodilation of the brachial artery and has used both of these techniques to study HIV-infected individuals with the purpose of ascertaining the pathophysiology of HIV-related cardiovascular disease and the role of inflammation in this disease process. She has published widely in the area of HIV-related cardiovascular disease and inflammation including high-impact publications in Circulation, JACC, and AIDS. Dr. Hsue runs the HIV Cardiology Clinic at San Francisco General Hospital and is one of the few cardiologists internationally with clinical as well as research expertise in this area. She is PI of a multicenter clinical trial to evaluate the cardiovascular impact of low dose methotrexate in HIV.



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek